生命科学公司安捷伦科技（A）在周三盘后交易中股价大涨6.55%，表现强劲。这一涨幅主要源于公司公布的第二季度财报超出市场预期，以及对全年业绩展望的上调。
根据公司发布的财报，安捷伦科技第二季度销售额达到16.7亿美元，高于分析师预期的16.3亿美元。经调整后的每股收益为1.31美元，同样超过了华尔街预期的1.26美元。公司的核心业务部门表现出色，其中生命科学和诊断部门的销售额为6.54亿美元，CrossLab部门的收入为7.13亿美元，均超出市场预期。
安捷伦科技还上调了全年营收预期，从此前的66.8亿美元至67.6亿美元区间提高到67.3亿美元至68.1亿美元之间。公司总裁兼首席执行官帕德雷格·麦克唐纳表示，安捷伦团队在高度动态的市场环境中取得了强劲的第二季度业绩。这一业绩表现和乐观展望显示，尽管近年来生物技术客户支出减少，但市场对安捷伦用于药物开发的工具和设备的需求仍然强劲，这为公司未来的增长奠定了良好基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.